Effects of retinoic acid and fenretinide on the c-erbB-2 expression, growth and cisplatin sensitivity of breast cancer cells

This publication has 40 references indexed in Scilit:

• Tyrosine kinase signaling pathways control the expression of retinoic acid receptor-α in SK-BR-3 breast cancer cells
  Cancer Letters, 1997
• Bidirectional interactions between the estrogen receptor and the c‐erbB‐2 signaling pathways: Heregulin inhibits estrogenic effects in breast cancer cells
  International Journal of Cancer, 1995
• Retinoids in Cancer Chemoprevention
  Annals of the New York Academy of Sciences, 1995
• Mechanism of interaction between cisplatin and human recombinant interferon gamma in human ovarian‐cancer cell lines
  International Journal of Cancer, 1995
• Different propensity for spontaneous differentiation of cell clones isolated from the human ovarian surface epithelial cell line HOC-7
  Differentiation, 1993
• Hormonal regulation of c-erbB-2 oncogene expression in breast cancer cells
  The Journal of Steroid Biochemistry and Molecular Biology, 1992
• The differential effects of N,N‐dimethylformamide and transforming growth factor‐β1 on a human ovarian cancer cell line (HOC‐7)
  Journal of Cellular Physiology, 1992
• Effects of interferons on the expression of the proto‐oncogene her‐2 in human ovarian carcinoma cells
  International Journal of Cancer, 1992
• Clinical Significance of erbB-2 (HER-2/neu) Protein
  Cancer Investigation, 1992
• Differentiation of cultured human breast cancer cells (AU‐565 and MCF‐7) associated with loss of cell surface HER‐2/neu antigen
  Molecular Carcinogenesis, 1990